Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment

Therapeutic antibodies are extensively used to treat fundus diseases by intravitreal injection, as eyedrop formulation has been rather challenging due to the presence of ocular barriers. Here, an innovative penetrating carrier was developed for antibody delivery in eyedrop formulations. We found tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jingjing, Gao, Huiqin, Chen, Linfu, Jiang, Yutong, Li, Shu, Chao, Yu, Liu, Nanhui, Wang, Yufei, Wei, Ting, Liu, Yan, Li, Jipeng, Chen, Muchao, Zhu, Jiafei, Liang, Juan, Zhou, Xiaoyu, Zhang, Xiaofeng, Gu, Ping, Chen, Qian, Liu, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882978/
https://www.ncbi.nlm.nih.gov/pubmed/36706184
http://dx.doi.org/10.1126/sciadv.abq3104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882978/
https://www.ncbi.nlm.nih.gov/pubmed/36706184
http://dx.doi.org/10.1126/sciadv.abq3104

Ejemplares similares